​

Spero Therapeutics Ownership | Who Owns Spero Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Spero Therapeutics Ownership Summary

Spero Therapeutics is owned by 22.75% institutional investors, 20.13% insiders, and 57.12% retail investors. Anson funds management lp is the largest institutional shareholder, holding 7.01% of SPRO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.16% of its assets in Spero Therapeutics shares.

SPRO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSpero Therapeutics22.75%20.13%57.12%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Anson funds management lp3.75M7.01%$4.88M
Vanguard group1.77M3.31%$2.30M
Acadian asset management1.07M2.00%$1.39M
Renaissance975.95K1.82%$1.27M
Adar1 capital management918.93K1.72%$1.19M
Alphabet889.98K1.66%$1.16M
Atlas venture life science advisors535.34K1.00%$695.94K
Geode capital management492.19K0.92%$639.99K
Blackrock483.40K0.90%$628.42K
Novo468.90K0.88%$609.57K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Anson funds management lp3.75M0.58%$4.88M
Adar1 capital management918.93K0.23%$1.19M
Atlas venture life science advisors535.34K0.07%$695.94K
Alphabet889.98K0.06%$1.16M
Awm investment company333.40K0.06%$433.42K
Dafna capital management125.00K0.04%$162.50K
Novo468.90K0.03%$609.57K
Dlk investment management31.36K0.02%$40.76K
Bridgeway capital management184.80K0.01%$240.24K
Shay capital25.00K0.00%$32.50K

Top Buyers

HolderShares% AssetsChange
Acadian asset management1.07M0.00%309.26K
Renaissance975.95K0.00%121.49K
Vanguard group1.77M-117.09K
Geode capital management492.19K0.00%22.75K
Blackrock483.40K-6.51K

Top Sellers

HolderShares% AssetsChange
Murchinson---873.91K
Shay capital25.00K0.00%-281.97K
Man group73.47K0.00%-140.56K
Bank of montreal /can/---79.50K
Squarepoint ops---79.40K

New Positions

HolderShares% AssetsChangeValue
Cullen/frost bankers2.00K-2.00K$2.60K
Royal bank of canada1.96K-1.96K$3.00K
Citadel advisors500.00-500.00$650.00

Sold Out

HolderChange
Qube research-1.00
Pfs partners-50.00
Raleigh capital management-500.00
Allworth financial lp-600.00
Ifp advisors-650.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202447-4.08%12,313,754-11.17%223.39%10-41.18%1250.00%
Jun 30, 202449-9.26%13,861,9790.87%253.81%17-29.17%8-33.33%
Mar 31, 20245412.50%13,742,012-0.56%263.79%2471.43%1220.00%
Dec 31, 202348-9.43%13,819,601-2.58%263.60%14-12.50%10-28.57%
Sep 30, 202353-8.62%14,186,051-1.23%263.61%16-30.43%147.69%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.17M2.16%-
Vanguard Institutional Extnd Mkt Idx Tr587.34K1.08%-
Fidelity Extended Market Index256.65K0.47%3.84K
Bridgeway Ultra-Small Company Market134.80K0.25%-
iShares Micro-Cap ETF107.49K0.20%-
Fidelity Total Market Index66.94K0.12%-164.00
BlackRock Extended Equity Market K60.57K0.11%-26.00
Fidelity Series Total Market Index59.97K0.11%-
Spartan Total Market Index Pool E50.89K0.09%-15.70K
NT Ext Equity Mkt Idx Fd - NL50.56K0.09%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 08, 2024Rajavelu Esther CFO & CBOSell$22.42K
Nov 07, 2024Rajavelu Esther CFO & CBOSell$30.59K
Aug 27, 2024Mahadevia Ankit-Sell$7.98K
Aug 27, 2024Keutzer Timothy Chief Operating OfficerSell$2.99K
Aug 27, 2024Shukla Sath CEO & PresidentSell$3.72K

Insider Transactions Trends

DateBuySell
2024 Q3-5
2024 Q2--
2024 Q1-6
2023 Q4--
2023 Q3-6

SPRO Ownership FAQ

Who Owns Spero Therapeutics?

Spero Therapeutics shareholders are primarily institutional investors at 22.75%, followed by 20.13% insiders and 57.12% retail investors. The average institutional ownership in Spero Therapeutics's industry, Biotech Stocks , is 47.04%, which Spero Therapeutics falls below.

Who owns the most shares of Spero Therapeutics?

Spero Therapeutics’s largest shareholders are Anson funds management lp (3.75M shares, 7.01%), Vanguard group (1.77M shares, 3.31%), and Acadian asset management (1.07M shares, 2.00%). Together, they hold 12.32% of Spero Therapeutics’s total shares outstanding.

Does Blackrock own Spero Therapeutics?

Yes, BlackRock owns 0.90% of Spero Therapeutics, totaling 483.4K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 628.42K$. In the last quarter, BlackRock increased its holdings by 6.51K shares, a 1.36% change.

Who is Spero Therapeutics’s biggest shareholder by percentage of total assets invested?

Anson funds management lp is Spero Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.58% of its assets in 3.75M Spero Therapeutics shares, valued at 4.88M$.

Who is the top mutual fund holder of Spero Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Spero Therapeutics shares, with 2.16% of its total shares outstanding invested in 1.17M Spero Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools